By Juby Babu April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge ...
The GPT-Rosalind model is designed to accelerate biological research and drug discovery. View on euronews ...
Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval Transaction led by Frazier Life Sciences, TPG Life Sciences Innovations, venBio ...
Strengthen Achieve's Position to Execute Development and Launch of Cytisinicline, if Approved, as the First New Treatment for Nicotine Dependence in Two Decades SEATTLE and VANCOUVER, British Columbia ...
Spain decided to set up the fund in Massachusetts because it wants to encourage Spanish entrepreneurs and startups to tap ...
Rosalind, to support research into biology, drug discovery and translational medicine. The model is built to improve scientific workflows by helping researchers analyze literature, generate hypotheses ...
Live Science on MSN
$3 million prize goes to duo whose research led to first sickle cell CRISPR therapy
Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...
Xtalks is pleased to announce its role as an official Media Partner for the Toronto Life Sciences and Biotech Summit, taking ...
Construction starts at Detroit's 'fail jail' site — a new BAMF‑Henry Ford theranostics center leads the project.
OpenAI’s new research says AI and ChatGPT can accelerate life sciences, cut drug R&D delays, and bridge gaps slowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results